These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 15198928)
1. Glycated albumin activates PAI-1 transcription through Smad DNA binding sites in mesangial cells. Lee HS; Moon KC; Song CY; Kim BC; Wang S; Hong HK Am J Physiol Renal Physiol; 2004 Oct; 287(4):F665-72. PubMed ID: 15198928 [TBL] [Abstract][Full Text] [Related]
2. Oxidized LDL activates PAI-1 transcription through autocrine activation of TGF-beta signaling in mesangial cells. Song CY; Kim BC; Hong HK; Lee HS Kidney Int; 2005 May; 67(5):1743-52. PubMed ID: 15840021 [TBL] [Abstract][Full Text] [Related]
3. Role of CAGA boxes in the plasminogen activator inhibitor-1 promoter in mediating oxidized low-density lipoprotein-induced transcriptional activation in mesangial cells. Kim BC; Song CY; Hong HK; Lee HS Transl Res; 2007 Sep; 150(3):180-8. PubMed ID: 17761371 [TBL] [Abstract][Full Text] [Related]
4. Advanced glycosylation end products stimulate collagen mRNA synthesis in mesangial cells mediated by protein kinase C and transforming growth factor-beta. Kim YS; Kim BC; Song CY; Hong HK; Moon KC; Lee HS J Lab Clin Med; 2001 Jul; 138(1):59-68. PubMed ID: 11433229 [TBL] [Abstract][Full Text] [Related]
5. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta. Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313 [TBL] [Abstract][Full Text] [Related]
6. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells. Poncelet AC; de Caestecker MP; Schnaper HW Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488 [TBL] [Abstract][Full Text] [Related]
7. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line. He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247 [TBL] [Abstract][Full Text] [Related]
8. Upstream stimulatory factor regulates E box-dependent PAI-1 transcription in human epidermal keratinocytes. Allen RR; Qi L; Higgins PJ J Cell Physiol; 2005 Apr; 203(1):156-65. PubMed ID: 15372465 [TBL] [Abstract][Full Text] [Related]
9. Lovastatin inhibits oxidized low-density lipoprotein-induced plasminogen activator inhibitor and transforming growth factor-beta1 expression via a decrease in Ras/extracellular signal-regulated kinase activity in mesangial cells. Song CY; Kim BC; Lee HS Transl Res; 2008 Jan; 151(1):27-35. PubMed ID: 18061125 [TBL] [Abstract][Full Text] [Related]
10. Tenascin-C upregulation by transforming growth factor-beta in human dermal fibroblasts involves Smad3, Sp1, and Ets1. Jinnin M; Ihn H; Asano Y; Yamane K; Trojanowska M; Tamaki K Oncogene; 2004 Mar; 23(9):1656-67. PubMed ID: 15001984 [TBL] [Abstract][Full Text] [Related]
11. Antisense targeting of c-fos transcripts inhibits serum- and TGF-beta 1-stimulated PAI-1 gene expression and directed motility in renal epithelial cells. Kutz SM; Providence KM; Higgins PJ Cell Motil Cytoskeleton; 2001 Mar; 48(3):163-74. PubMed ID: 11223948 [TBL] [Abstract][Full Text] [Related]
12. Functional cooperation between Smad proteins and activator protein-1 regulates transforming growth factor-beta-mediated induction of endothelin-1 expression. RodrÃguez-Pascual F; Redondo-Horcajo M; Lamas S Circ Res; 2003 Jun; 92(12):1288-95. PubMed ID: 12764024 [TBL] [Abstract][Full Text] [Related]
13. Synthetic triterpenoids enhance transforming growth factor beta/Smad signaling. Suh N; Roberts AB; Birkey Reffey S; Miyazono K; Itoh S; ten Dijke P; Heiss EH; Place AE; Risingsong R; Williams CR; Honda T; Gribble GW; Sporn MB Cancer Res; 2003 Mar; 63(6):1371-6. PubMed ID: 12649201 [TBL] [Abstract][Full Text] [Related]
14. Transforming growth factor-beta induced collagenase-3 production in human osteoarthritic chondrocytes is triggered by Smad proteins: cooperation between activator protein-1 and PEA-3 binding sites. Tardif G; Reboul P; Dupuis M; Geng C; Duval N; Pelletier JP; Martel-Pelletier J J Rheumatol; 2001 Jul; 28(7):1631-9. PubMed ID: 11469472 [TBL] [Abstract][Full Text] [Related]
15. Restoration of TGF-beta regulation of plasminogen activator inhibitor-1 in Smad3-restituted human choriocarcinoma cells. Xu G; Chakraborty C; Lala PK Biochem Biophys Res Commun; 2002 Jun; 294(5):1079-86. PubMed ID: 12074587 [TBL] [Abstract][Full Text] [Related]
16. Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells. Schacke W; Beck KF; Pfeilschifter J; Koch F; Hattenbach LO Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2799-805. PubMed ID: 12147618 [TBL] [Abstract][Full Text] [Related]
17. Smad pathway is activated in the diabetic mouse kidney and Smad3 mediates TGF-beta-induced fibronectin in mesangial cells. Isono M; Chen S; Hong SW; Iglesias-de la Cruz MC; Ziyadeh FN Biochem Biophys Res Commun; 2002 Sep; 296(5):1356-65. PubMed ID: 12207925 [TBL] [Abstract][Full Text] [Related]